Literature DB >> 11804210

Self-rated psychosocial consequences and quality of life in the acute porphyrias.

L M Millward1, P Kelly, A Deacon, V Senior, T J Peters.   

Abstract

A battery of self-report psychosocial measures was mailed to 116 patients who had been referred for clinical management (clinic attenders) or laboratory diagnosis (non-clinic attenders) to the London Supraregional Assay Service Centre for Porphyria over the past decade and who tested positive for porphyria. Usable replies were received from 81 (70%) patients. Our interest focused on the prevalence of psychosocial symptoms in acute porphyrias and the perceived effects of porphyria on quality of life and patient experience. Research questions examined included (i), lifestyle factors; (ii) life events; (iii) mental health; (iv) general health; and (v) perceptions of illness of patients receiving specialist clinical management compared to respondents referred for diagnostic investigations, between patients with latent or manifest symptomology and between patients with different types of porphyria. Patients with porphyria have an impaired quality of life, particularly manifest cases, compared to controls and to diabetic patients. Depression, and particularly anxiety, is more common than in the general population or general medical outpatient attenders. Quality oflife is lower in acute intermittent porphyria (AIP) than in other forms of porphyria and a significant number of patients had major life event consequences, e.g. failure to secure, or loss of, employment, limitation of family size. Patients attending a clinic providing specialist porphyria advice, management and counselling received some perceived lifestyle benefits.

Entities:  

Mesh:

Year:  2001        PMID: 11804210     DOI: 10.1023/a:1012901607040

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  23 in total

Review 1.  Porphyria: reexamination of psychiatric implications.

Authors:  K Burgovne; R Swartz; J Ananth
Journal:  Psychother Psychosom       Date:  1995       Impact factor: 17.659

2.  Efficacy of the alcohol use disorders identification test as a screening tool for hazardous alcohol intake and related disorders in primary care: a validity study.

Authors:  M Piccinelli; E Tessari; M Bortolomasi; O Piasere; M Semenzin; N Garzotto; M Tansella
Journal:  BMJ       Date:  1997-02-08

3.  Identifying hazardous or harmful alcohol use in medical admissions: a comparison of audit, cage and brief mast.

Authors:  D MacKenzie; A Langa; T M Brown
Journal:  Alcohol Alcohol       Date:  1996-11       Impact factor: 2.826

Review 4.  A review of research on the Alcohol Use Disorders Identification Test (AUDIT).

Authors:  J P Allen; R Z Litten; J B Fertig; T Babor
Journal:  Alcohol Clin Exp Res       Date:  1997-06       Impact factor: 3.455

5.  The MOS short-form general health survey. Reliability and validity in a patient population.

Authors:  A L Stewart; R D Hays; J E Ware
Journal:  Med Care       Date:  1988-07       Impact factor: 2.983

6.  A survey of porphyria among psychiatric patients.

Authors:  R McEwin; J Lawn; C T Jonas
Journal:  Med J Aust       Date:  1972-08-05       Impact factor: 7.738

7.  Varied psychiatric manifestations of acute intermittent porphyria.

Authors:  P J Santosh; S Malhotra
Journal:  Biol Psychiatry       Date:  1994-12-01       Impact factor: 13.382

8.  The Medical Outcomes Study Instrument (MOSI)--use of a new health status measure in Britain.

Authors:  J S Anderson; F Sullivan; T P Usherwood
Journal:  Fam Pract       Date:  1990-09       Impact factor: 2.267

Review 9.  Alcohol and porphyrin metabolism.

Authors:  M O Doss; A Kühnel; U Gross
Journal:  Alcohol Alcohol       Date:  2000 Mar-Apr       Impact factor: 2.826

10.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

Authors:  A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

View more
  15 in total

Review 1.  Quality of life in rare genetic conditions: a systematic review of the literature.

Authors:  Julie S Cohen; Barbara B Biesecker
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

2.  Anxiety and depression in the acute porphyrias.

Authors:  L M Millward; P Kelly; A King; T J Peters
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in norwegian minors.

Authors:  Janice Andersen; Sverre Sandberg; Maalfrid Raaheim; Eva Gjengedal
Journal:  JIMD Rep       Date:  2011-06-22

4.  Experiences and concerns of patients with recurrent attacks of acute hepatic porphyria: A qualitative study.

Authors:  Hetanshi Naik; Mikayla Stoecker; Saskia C Sanderson; Manisha Balwani; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2016-08-24       Impact factor: 4.797

Review 5.  Acute hepatic porphyrias: Recommendations for evaluation and long-term management.

Authors:  Manisha Balwani; Bruce Wang; Karl E Anderson; Joseph R Bloomer; D Montgomery Bissell; Herbert L Bonkovsky; John D Phillips; Robert J Desnick
Journal:  Hepatology       Date:  2017-09-04       Impact factor: 17.425

Review 6.  The acute hepatic porphyrias.

Authors:  Bruce Wang
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

Review 7.  Psychological Aspect and Quality of Life in Porphyrias: A Review.

Authors:  Granata Francesca; Annamaria Nicolli; Alessia Colaiocco; Elena Di Pierro; Giovanna Graziadei
Journal:  Diagnostics (Basel)       Date:  2022-05-10

8.  Medical and financial burden of acute intermittent porphyria.

Authors:  Rochus A Neeleman; Margreet A E M Wagenmakers; Rita H Koole-Lesuis; G Sophie Mijnhout; J H Paul Wilson; Edith C H Friesema; Janneke G Langendonk
Journal:  J Inherit Metab Dis       Date:  2018-04-19       Impact factor: 4.982

9.  Anthropometric and Quality-of-Life Parameters in Acute Intermittent Porphyria Patients.

Authors:  Antonia M Jiménez-Monreal; MAntonia Murcia; Victoria Gómez-Murcia; Maria Del Mar Bibiloni; Antoni Pons; Josep A Tur; Magdalena Martínez-Tomé
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

10.  Acute Intermittent Porphyria in the North of China: The Acute Attack Effect on Quality of Life and Psychological Condition.

Authors:  Jing Yang; Tienan Zhu; Yongqiang Zhao; Xuezhong Yu; Huadong Zhu; Yinan Jiang; Xiaoqing Li
Journal:  Biomed Res Int       Date:  2018-05-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.